Terms: = Endocrine gland cancer AND WHSC1, 7468, O96028, WHS, TRX5, REIIBP, NSD2, MMSET, MGC176638, KIAA1090, FLJ23286
15 results:
1. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer.
Xiong Q; Zhou Y; Zhang S; Zhang Y; Xu Y; Yang Y; Zhou C; Zeng Z; Han J; Zhu Q
Cancer Med; 2023 May; 12(9):10961-10978. PubMed ID: 37062069
[TBL] [Abstract] [Full Text] [Related]
2. Cytotoxic Chemotherapy for Pancreatic Adenocarcinoma in England 2010-2017: Survival Outcomes.
Wang Z; Lord S; Darby S; Dodwell D
Clin Oncol (R Coll Radiol); 2023 Jun; 35(6):382-396. PubMed ID: 36948915
[TBL] [Abstract] [Full Text] [Related]
3. Somatic tumor mutations in moderate risk cancer genes: Targets for germline confirmatory testing.
Llorin H; Graf M; Chun N; Ford J
Cancer Genet; 2022 Nov; 268-269():22-27. PubMed ID: 36116289
[TBL] [Abstract] [Full Text] [Related]
4. The histone methyltransferase whsc1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
Kojima M; Sone K; Oda K; Hamamoto R; Kaneko S; Oki S; Kukita A; Machino H; Honjoh H; Kawata Y; Kashiyama T; Asada K; Tanikawa M; Mori-Uchino M; Tsuruga T; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Osuga Y; Fujii T
BMC Cancer; 2019 May; 19(1):455. PubMed ID: 31092221
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic cancer Patients Receiving Neoadjuvant Treatment.
Yoon KA; Woo SM; Kim YH; Kong SY; Lee MK; Han SS; Kim TH; Lee WJ; Park SJ
Gut Liver; 2019 Nov; 13(6):683-689. PubMed ID: 30970447
[TBL] [Abstract] [Full Text] [Related]
6. Migraine and invasive epithelial ovarian cancer risk in the Nurses' Health Study II and the Women's Health Study.
Rice MS; Rist PM; Winter AC; Kurth T; Tworoger SS
Int J Cancer; 2018 Feb; 142(3):534-539. PubMed ID: 28929486
[TBL] [Abstract] [Full Text] [Related]
7. E2F2 induces MCM4, CCNE2 and whsc1 upregulation in ovarian cancer and predicts poor overall survival.
Xie L; Li T; Yang LH
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2150-2156. PubMed ID: 28537669
[TBL] [Abstract] [Full Text] [Related]
8. Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages.
Brabrand S; Johannessen B; Axcrona U; Kraggerud SM; Berg KG; Bakken AC; Bruun J; Fosså SD; Lothe RA; Lehne G; Skotheim RI
Neoplasia; 2015 Feb; 17(2):167-74. PubMed ID: 25748235
[TBL] [Abstract] [Full Text] [Related]
9. Rasch analysis for assessing unidimensionality and identifying measurement biases of malignancy scores in oncology. The example of the Weiss histopathological system for the diagnosis of adrenocortical cancer.
Coste J; Tissier F; Pouchot J; Ecosse E; Rouquette A; Bertagna X; Libé R; Viallon V
Cancer Epidemiol; 2014 Apr; 38(2):200-8. PubMed ID: 24631426
[TBL] [Abstract] [Full Text] [Related]
10. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.
Poole EM; Lee IM; Ridker PM; Buring JE; Hankinson SE; Tworoger SS
Am J Epidemiol; 2013 Oct; 178(8):1256-64. PubMed ID: 23966559
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of multiple myeloma SET domain (mmset) is associated with advanced tumor aggressiveness and poor prognosis in serous ovarian carcinoma.
Yang S; Zhang Y; Meng F; Liu Y; Xia B; Xiao M; Xu Y; Ning X; Li H; Lou G
Biomarkers; 2013 May; 18(3):257-63. PubMed ID: 23566000
[TBL] [Abstract] [Full Text] [Related]
12. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.
Wolpin BM; Ng K; Bao Y; Kraft P; Stampfer MJ; Michaud DS; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Cochrane BB; Wactawski-Wende J; Chlebowski RT; Willett WC; Manson JE; Giovannucci EL; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):82-91. PubMed ID: 22086883
[TBL] [Abstract] [Full Text] [Related]
13. Plasma androgen concentrations and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Hankinson SE
Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156
[TBL] [Abstract] [Full Text] [Related]
14. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
[TBL] [Abstract] [Full Text] [Related]
15. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Rosner B; Hollis BW; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):783-8. PubMed ID: 17416771
[TBL] [Abstract] [Full Text] [Related]